News & AnalysisLycia Therapeutics lands $50mBiotechnology company Lycia Therapeutics, Inc has secured $50 million in funding.ByIris Dorbian9 June 2020•1 min readJavaScript is required to read this article. Please enable it in your browser and reload the page.DealsHealthcareBriefs